Effect of peer groups on life quality and treatment adherence in patients affected by breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201102055766N1

Enrollment

Registered

2011-03-19

Start date

2010-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: The Control group: Also in the control group the patients participated in 6 educational sessions held on their disease, its treatment and complications and similar subjects. Each educ

The Control group: Also in the control group the patients participated in 6 educational sessions held on their disease, its treatment and complications and similar subjects. Each educational session

In experimental group, patients were divided into two groups of 17 in order to participate in peer groups. In each group, two of the leaders were in charge of holding and conducting the sessions. The

Eligibility

Sex/Gender

Female

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included women with breast cancer with 20 to 65 years f age who have had mastectomy 6 months to 2 years before and at the time of study were receiving therapy – whether radiotherapy or medical treatment. Patients should have been be in stage II and III of non-metastatic breast cancer, who had no chronic disabling underlying condition (such as major depression or any other condition which would prevent them from participating in sessions). Also the patients should meet the literacy needed to fill in the questionnaires and have never had participated in such supportive programs before. Exclusion criteria were patients who would discontinue voluntarily, patients developing any mental or physical disease which would prevent them from continuing the study, those who were absent 2 consecutive sessions and those who got aware of the other group and had meanwhile took part in their sessions.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Quality of life. Timepoint: 3 months. Method of measurement: questionnaire.;Treatment adherence. Timepoint: 3 months. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsaneh Malekpour Tehrani

Isfahan University of Medical Sciences

a_malekpour@resident.mui.ac.ir , afsanehmalekpour@yahoo.com+98 31 1627 3708

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026